160 related articles for article (PubMed ID: 32003460)
21. Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.
Berretta M; Martellotta F; Di Francia R; Spina M; Vaccher E; Balestreri L; Borsatti E; Bearz A; De Paoli P; Tirelli U
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3619-34. PubMed ID: 26502852
[TBL] [Abstract][Full Text] [Related]
22. Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era.
Bedimo R
Curr HIV/AIDS Rep; 2008 Aug; 5(3):140-9. PubMed ID: 18627663
[TBL] [Abstract][Full Text] [Related]
23. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
Sachdeva RK; Sharma A; Singh S; Varma S
Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
[TBL] [Abstract][Full Text] [Related]
25. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
[TBL] [Abstract][Full Text] [Related]
26. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
27. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
28. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms.
Franceschi S; Dal Maso L; La Vecchia C
Int J Cancer; 1999 Nov; 83(4):481-5. PubMed ID: 10508483
[TBL] [Abstract][Full Text] [Related]
29. Survival after cancer in Italian persons with AIDS, 1986-2005: a population-based estimation.
Dal Maso L; Suligoi B; Franceschi S; Braga C; Buzzoni C; Polesel J; Zucchetto A; Piselli P; Falcini F; Caldarella A; Zanetti R; Vercelli M; Guzzinati S; Russo A; Tagliabue G; Iachetta F; Ferretti S; Limina RM; Mangone L; Michiara M; Stracci F; Pirino DR; Piffer S; Giacomin A; Vitarelli S; Mazzoleni G; Iannelli A; Contrino ML; Fusco M; Tumino R; Fanetti AC; De Paoli P; Decarli A; Serraino D;
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):428-35. PubMed ID: 24798769
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
Rubio R
Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
[TBL] [Abstract][Full Text] [Related]
31. Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries.
Trickey A; Glaubius R; Pantazis N; Zangerle R; Wittkop L; Vehreschild J; Grabar S; Cavassini M; Teira R; d'Arminio Monforte A; Casabona J; van Sighem A; Jarrin I; Ingle SM; Sterne JAC; Imai-Eaton JW; Johnson LF
J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e89-e96. PubMed ID: 38180742
[TBL] [Abstract][Full Text] [Related]
32. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
[TBL] [Abstract][Full Text] [Related]
33. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990.
Koblin BA; Hessol NA; Zauber AG; Taylor PE; Buchbinder SP; Katz MH; Stevens CE
Am J Epidemiol; 1996 Nov; 144(10):916-23. PubMed ID: 8916502
[TBL] [Abstract][Full Text] [Related]
34. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
35. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
36. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors.
Andrieu JM; Roithmann S; Tourani JM; Levy R; Desablens B; le Maignan C; Gastaut JA; Brice P; Raphael M; Taillan B
Ann Oncol; 1993 Sep; 4(8):635-41. PubMed ID: 8240994
[TBL] [Abstract][Full Text] [Related]
38. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
39. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
40. High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.
Squillace N; Galli L; Bandera A; Castagna A; Madeddu G; Caramello P; Antinori A; Cattelan A; Maggiolo F; Cingolani A; Gori A; Monforte AD;
Medicine (Baltimore); 2016 Sep; 95(36):e4434. PubMed ID: 27603338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
